Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha.

BACKGROUND It has been reported that tumor necrosis factor-alpha (TNF-alpha) is expressed in the heart with viral myocarditis and that its expression aggravates the condition. The pathophysiological effects of TNF-alpha on viral myocarditis, however, have not been fully elucidated. METHODS AND RESULTS To investigate the role of TNF-alpha in the progression of viral myocarditis, we used TNF-alpha gene-deficient mice (TNF-alpha(-/-)) and induced acute myocarditis by infection with encephalomyocarditis virus (EMCV). The survival rate of TNF-alpha(-/-) mice after EMCV infection was significantly lower than that of TNF-alpha(+/+) mice (0% versus 67% on day 14). Injection of recombinant human TNF-alpha (0.2 to 4.0 microg/mouse IV) improved the survival of TNF-alpha(-/-) mice in a dose-dependent manner, indicating that TNF-alpha is essential for protection against viral myocarditis. The levels of viral titer and viral genomic RNA of EMCV in the myocardium were significantly higher in TNF-alpha(-/-) than in TNF-alpha(+/+) mice. Histopathological examination showed that the inflammatory changes of the myocardium were less marked in TNF-alpha(-/-) than in TNF-alpha(+/+) mice. Immunohistochemical analysis revealed that the levels of immunoreactivity of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the myocardium were decreased in TNF-alpha(-/-) mice compared with TNF-alpha(+/+) mice. CONCLUSIONS These observations suggested that TNF-alpha is necessary for adhesion molecule expression and to recruit leukocytes to inflammatory sites, and thus, the lack of this cytokine resulted in failure of elimination of infectious agents. We concluded that TNF-alpha plays a protective role in the acute stage of viral myocarditis.

[1]  V. Racaniello.  Picornaviridae : the viruses and their replication , 2001 .

[2]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[3]  R. Kandolf,et al.  Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. , 1998, Circulation.

[4]  M. Bristow.  Tumor Necrosis Factor-a and Cardiomyopathy , 1998 .

[5]  R. Peshock,et al.  Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. , 1998, Circulation.

[6]  F. Clubb,et al.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.

[7]  G. Freeman,et al.  Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. , 1998, American journal of physiology. Heart and circulatory physiology.

[8]  E. Momotani,et al.  Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[9]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[10]  R. Crystal,et al.  Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors , 1997 .

[11]  L. Old,et al.  Characterization of tumor necrosis factor-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Chisari.  Cytotoxic T cells and viral hepatitis. , 1997, The Journal of clinical investigation.

[13]  M. Entman,et al.  Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac Myocytes , 1997 .

[14]  T. Mak,et al.  Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. , 1997, Circulation.

[15]  A. Matsumori,et al.  Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. , 1996, Circulation.

[16]  M. Bristow,et al.  Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.

[17]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[18]  J. Banchereau,et al.  Mutant mice without B lymphocyte follicles , 1996, The Journal of experimental medicine.

[19]  B. McManus,et al.  Modification of viral myocarditis in mice by interleukin-6. , 1996, Circulation research.

[20]  T. Mak,et al.  Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. , 1996, Journal of immunology.

[21]  G. Freeman,et al.  Tumor Necrosis Factor-α Induces a Biphasic Effect on Myocardial Contractility in Conscious Dogs , 1996 .

[22]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[23]  H. Werner,et al.  Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. , 1995, American journal of respiratory and critical care medicine.

[24]  A. Matsumori,et al.  Increased circulating cytokines in patients with myocarditis and cardiomyopathy. , 1994, British heart journal.

[25]  S. Huber.  VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells , 1994, Journal of virology.

[26]  S. Sasayama,et al.  Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. , 1994, Circulation.

[27]  A. Matsumori,et al.  Therapeutic Effect of Anti‐Tumor Necrosis Factor‐α Antibody on the Murine Model of Viral Myocarditis Induced by Encephalomyocarditis Virus , 1994, Circulation.

[28]  K. Tracey,et al.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.

[29]  F. Chisari,et al.  Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice , 1992, Journal of virology.

[30]  P. Allen,et al.  Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. , 1992, Circulation research.

[31]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[32]  D. Hossfeld,et al.  TNF-induced cardiomyopathy , 1990, The Lancet.

[33]  G. Wong,et al.  Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.

[34]  M. Yamada,et al.  Efficient production of a human tumour necrosis factor in Escherichia coli. , 1985, Nucleic acids symposium series.

[35]  A. Matsumori,et al.  An Experimental Model for Congestive Heart Failure After Encephalomyocarditis Virus Myocarditis in Mice , 1982, Circulation.